Method for treatment of a human patient having hypoadiponectinemia. 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl]thiazolidine-- 2,4-dione or a pharmacologically salt thereof is administered in an amount effective to raise the level of adiponectine in said patient.